These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 37460942)
1. Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study. Pascual J; Panni T; Dell'Agnello G; Gonderten S; Novick D; Evers S J Headache Pain; 2023 Jul; 24(1):88. PubMed ID: 37460942 [TBL] [Abstract][Full Text] [Related]
2. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences. Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895 [TBL] [Abstract][Full Text] [Related]
3. Acute Treatment Patterns, Migraine Burden, and Healthcare Resource Use in People With Migraine: Results From the OVERCOME (EU) Observational Study. Evers S; Dell'Agnello G; Novick D; Gonderten HS; Panni T; Pascual J Pain Ther; 2024 Jun; 13(3):589-607. PubMed ID: 38625512 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study. Hirata K; Ueda K; Komori M; Zagar AJ; Selzler KJ; Nelson AM; Han Y; Jaffe DH; Matsumori Y; Takeshima T Curr Med Res Opin; 2021 Nov; 37(11):1945-1955. PubMed ID: 34429000 [TBL] [Abstract][Full Text] [Related]
5. Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study. Buse DC; Sakai F; Matharu M; Reed ML; Fanning K; Dabruzzo B; Lipton RB Headache; 2024 May; 64(5):469-481. PubMed ID: 38706199 [TBL] [Abstract][Full Text] [Related]
6. Burden and Unmet Needs in Migraine Patients: Results from the OVERCOME (Spain) Study. Pascual J; Núñez M; Panni T; Díaz-Cerezo S; Novick D; Ciudad A Pain Ther; 2023 Oct; 12(5):1209-1220. PubMed ID: 37458965 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study. Lipton RB; Nicholson RA; Reed ML; Araujo AB; Jaffe DH; Faries DE; Buse DC; Shapiro RE; Ashina S; Cambron-Mellott MJ; Rowland JC; Pearlman EM Headache; 2022 Feb; 62(2):122-140. PubMed ID: 35076091 [TBL] [Abstract][Full Text] [Related]
8. Real-world treatment satisfaction with erenumab in migraine: analysis of the US National Health and Wellness Survey. Pathak P; Yue L; Gupta S; Fang J; Cheadle MA; Tiwari S; Ferraris M; Joshi P; Thompson J; Shah R; Vo P Curr Med Res Opin; 2023 Dec; 39(12):1585-1591. PubMed ID: 36919462 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial. Mulleners WM; Kim BK; Láinez MJA; Lanteri-Minet M; Pozo-Rosich P; Wang S; Tockhorn-Heidenreich A; Aurora SK; Nichols RM; Yunes-Medina L; Detke HC Lancet Neurol; 2020 Oct; 19(10):814-825. PubMed ID: 32949542 [TBL] [Abstract][Full Text] [Related]
10. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Diamond S; Bigal ME; Silberstein S; Loder E; Reed M; Lipton RB Headache; 2007 Mar; 47(3):355-63. PubMed ID: 17371352 [TBL] [Abstract][Full Text] [Related]
11. Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Dodick DW; Loder EW; Manack Adams A; Buse DC; Fanning KM; Reed ML; Lipton RB Headache; 2016 May; 56(5):821-834. PubMed ID: 27143127 [TBL] [Abstract][Full Text] [Related]
12. Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine. Robblee J; Devick KL; Mendez N; Potter J; Slonaker J; Starling AJ Headache; 2020 Oct; 60(9):2014-2025. PubMed ID: 32920850 [TBL] [Abstract][Full Text] [Related]
13. Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort : Results from 'Migraine in Poland'-a nationwide cross-sectional survey. Waliszewska-Prosół M; Straburzyński M; Czapińska-Ciepiela EK; Nowaczewska M; Gryglas-Dworak A; Budrewicz S J Headache Pain; 2023 Apr; 24(1):40. PubMed ID: 37041492 [TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
15. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Lipton RB; Hutchinson S; Ailani J; Reed ML; Fanning KM; Manack Adams A; Buse DC Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244 [TBL] [Abstract][Full Text] [Related]
16. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study. Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896 [TBL] [Abstract][Full Text] [Related]
18. Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study. Lipton RB; Munjal S; Buse DC; Alam A; Fanning KM; Reed ML; Schwedt TJ; Dodick DW Headache; 2019 Sep; 59(8):1310-1323. PubMed ID: 31410844 [TBL] [Abstract][Full Text] [Related]
19. Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatment. Buse DC; Pozo-Rosich P; Dupont-Benjamin L; Balkaran BL; Lee L; Jauregui A; Gandhi P; Parikh M; Reuter U J Headache Pain; 2023 Aug; 24(1):115. PubMed ID: 37612633 [TBL] [Abstract][Full Text] [Related]
20. Results of a Web-Based Survey on 2105 Greek Migraine Patients-Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients' Reported Satisfaction. Dermitzakis EV; Kouroudi A; Argyriou AA; Spingos KC; Bilias K; Vikelis M Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676655 [No Abstract] [Full Text] [Related] [Next] [New Search]